F-R Pruvot

Author PubWeight™ 9.43^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma.	Aliment Pharmacol Ther	2003	1.25
2	Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score.	Aliment Pharmacol Ther	2011	1.17
3	Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.	Br J Surg	2005	1.09
4	Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation.	Gastroenterol Clin Biol	2009	1.06
5	Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection.	Eur J Surg Oncol	2012	0.94
6	Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases.	Br J Cancer	2004	0.86
7	[Dermoid cyst of the diaphragm: a case report].	J Chir (Paris)	2009	0.84
8	Docetaxel therapy for advanced hepatocellular carcinoma developed in healthy liver: report of three cases.	J Chemother	2008	0.83
9	Management of blunt hepatic trauma.	J Visc Surg	2010	0.81
10	Surgical management of liver metastases from gastrointestinal endocrine tumors.	Gastroenterol Clin Biol	2010	0.79
11	[Metachronous cancer of common bile duct after resection of an intrahepatic cholangiocarcinoma].	Gastroenterol Clin Biol	2010	0.75
12	Exposure for hepatic surgery in the obese patient: an innovative adaptation in time of need….	J Visc Surg	2012	0.75